KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Liabilities and Shareholders Equity (2016 - 2025)

Cardinal Health's Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $58.1 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 23.58% year-over-year to $58.1 billion; the TTM value through Dec 2025 reached $216.3 billion, up 19.46%, while the annual FY2025 figure was $53.1 billion, 17.73% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $58.1 billion at Cardinal Health, up from $55.2 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $58.1 billion in Q4 2025 and bottomed at $42.1 billion in Q1 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $44.2 billion (2021), against an average of $46.2 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity dropped 4.02% in 2022 before it increased 28.26% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $43.7 billion in 2021, then increased by 1.84% to $44.5 billion in 2022, then increased by 4.7% to $46.6 billion in 2023, then grew by 0.92% to $47.0 billion in 2024, then rose by 23.58% to $58.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CAH's Liabilities and Shareholders Equity are $58.1 billion (Q4 2025), $55.2 billion (Q3 2025), and $53.1 billion (Q2 2025).